
- Pharmaceutical Technology-08-02-2015
- Volume 39
- Issue 8
Syringe Closure System Allows Use of Highly Sensitive Compounds
Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics.
Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics. The system’s baked-in siliconization process for the glass barrel allows the silicon content to be customized. The percentage of silicon used can be reduced up to 80% compared to standard siliconization processes used in conventional syringe systems, which makes the system suitable for silicon-sensitive drug products. The closure is tamper-evident; plastic bridges are broken when the needle shield is removed. The system can be used with a wide range of primary packaging options, such as stoppers and glass barrels.
Vetter Pharma International GmbH
Articles in this issue
almost 11 years ago
Getting Comfortable With Leanalmost 11 years ago
Black Specks in Tablet Stability Samplesalmost 11 years ago
Environmental Containment Performance—Is There Accountability?almost 11 years ago
Implementing Electronic Production Recordsalmost 11 years ago
Understanding Risks in Pharmaceutical Shippingalmost 11 years ago
Outsourcing Becoming More Cost Competitivealmost 11 years ago
Regulation of Medical Devices and Companion Diagnosticsalmost 11 years ago
Campaign Against Fake Drugs Gains Momentumalmost 11 years ago
Defining Crucial CAPA Componentsalmost 11 years ago
Taking the Pulse of Manufacturing Trends and Equipment Use



